Filtered By:
Cancer: Lymphoma
This page shows you your search results in order of date. This is page number 5.
Order by Relevance | Date
Total 25370 results found since Jan 2013.
LC-PDA-QTof-MS characterization of the stress degradation products of Zanubrutinib: A novel BTK inhibitor
This study provides comprehensive information on the inherent stability of ZAN which will be useful in the drug development and manufacturing processes.PMID:37713985 | DOI:10.1016/j.jpba.2023.115714
Source: Biomed Res - September 15, 2023 Category: Research Authors: Murali Mohan Bhandi Debasish Swain Srinivas Ragampeta Mohana Krishna Reddy Mudiam Source Type: research
BACH1 loss exerts antitumor effects on mantle cell lymphoma cells via inducing a tumor-intrinsic innate immune response and cell cycle arrest
Mol Cancer Res. 2023 Sep 15. doi: 10.1158/1541-7786.MCR-23-0424. Online ahead of print.ABSTRACTBTB and CNC homology 1 (BACH1) is a transcription repressor that regulates multiple physiological processes including intracellular heme homeostasis and immune responses. Increasing lines of evidence indicate that BACH1 reshapes metastasis and metabolism of human solid tumors. However, its potential roles in mantle cell lymphoma (MCL) remain largely unknown. Here we found that silencing BACH1 in MCL cells induced markedly cell-cycle arrest and cell apoptosis, whereas overexpression of BACH1 exhibited the opposite patterns. Increa...
Source: Cell Research - September 15, 2023 Category: Cytology Authors: Guilan Li Min Feng Ziting Zhang Jiangyuan Liu Han Zhang Source Type: research
Firefighters Fear the Toxic Chemicals in Their Gear Could Be Causing Cancer
BOSTON (AP) — Boston firefighter Daniel Ranahan had heard about colleagues getting cancer but he was stunned when doctors discovered a tumor in his chest.
He was only 30 and had been in the Boston Fire Department less than a decade. But as he investigated his diagnosis of Hodgkin’s lymphoma in October 2020 and sought successful treatment, he learned he and others wore gear that contained the toxic industrial compound PFAS.
[time-brightcove not-tgx=”true”]
“You always hear about the dangers. You just never think it’s going be you,” said Ranahan, who stopped working due to the...
Source: TIME: Health - September 14, 2023 Category: Consumer Health News Authors: MICHAEL CASEY / AP Tags: Uncategorized wire Source Type: news
A phase II study of interrupted and continuous dose lenalidomide in relapsed/refractory Hodgkin lymphoma
Haematologica. 2023 Sep 14. doi: 10.3324/haematol.2022.282246. Online ahead of print.ABSTRACTNot available.PMID:37706336 | DOI:10.3324/haematol.2022.282246
Source: Haematologica - September 14, 2023 Category: Hematology Authors: Todd A Fehniger Marcus P Watkins Nkiruka Ezenwajiaku Fei Wan David D Hurd Amanda F Cashen Kristie A Blum Andre Goy Timothy S Fenske Nina D Wagner-Johnston Kenneth Carson Marilyn J Siegel David Russler-Germain Stephanie E Schneider Neha Mehta-Shah Brad Kah Source Type: research
Diffuse large B-cell lymphoma involving the central nervous system: biologic rationale for targeted therapy
Haematologica. 2023 Sep 14. doi: 10.3324/haematol.2021.278613. Online ahead of print.ABSTRACTDiffuse large B-cell lymphoma (DLBCL) is an aggressive B-cell lymphoma curable even in advanced stages. DLBCL involving the central nervous system (CNS) is more difficult to cure and fewer treatment options exist. Primary CNS lymphoma (PCNSL) refers to aggressive lymphomas confined to the CNS, and are almost always DLBCL. Standard approaches for PCNSL use high-dose methotrexate based combinations as induction therapy and younger patients often receive dose-intensive consolidation. However, dose-intensive therapies are not suitable ...
Source: Haematologica - September 14, 2023 Category: Hematology Authors: Mark Roschewski Daniel J Hodson Source Type: research
A phase II study of interrupted and continuous dose lenalidomide in relapsed/refractory Hodgkin lymphoma
Haematologica. 2023 Sep 14. doi: 10.3324/haematol.2022.282246. Online ahead of print.ABSTRACTNot available.PMID:37706336 | DOI:10.3324/haematol.2022.282246
Source: Haematologica - September 14, 2023 Category: Hematology Authors: Todd A Fehniger Marcus P Watkins Nkiruka Ezenwajiaku Fei Wan David D Hurd Amanda F Cashen Kristie A Blum Andre Goy Timothy S Fenske Nina D Wagner-Johnston Kenneth Carson Marilyn J Siegel David Russler-Germain Stephanie E Schneider Neha Mehta-Shah Brad Kah Source Type: research
Diffuse large B-cell lymphoma involving the central nervous system: biologic rationale for targeted therapy
Haematologica. 2023 Sep 14. doi: 10.3324/haematol.2021.278613. Online ahead of print.ABSTRACTDiffuse large B-cell lymphoma (DLBCL) is an aggressive B-cell lymphoma curable even in advanced stages. DLBCL involving the central nervous system (CNS) is more difficult to cure and fewer treatment options exist. Primary CNS lymphoma (PCNSL) refers to aggressive lymphomas confined to the CNS, and are almost always DLBCL. Standard approaches for PCNSL use high-dose methotrexate based combinations as induction therapy and younger patients often receive dose-intensive consolidation. However, dose-intensive therapies are not suitable ...
Source: Haematologica - September 14, 2023 Category: Hematology Authors: Mark Roschewski Daniel J Hodson Source Type: research
Anticancer Effects of Cell-Free Culture Supernatant of Escherichia coli in Bladder Cancer Cell Line: New Insight into the Regulation of Inflammation
In conclusion, our findings demonstrate that this compound is a potential candidate for the suppression of bladder cancer progression.PMID:37708921 | DOI:10.1016/j.gene.2023.147795
Source: Gene - September 14, 2023 Category: Genetics & Stem Cells Authors: Amirreza Mehmandar-Oskuie Masoud Tohidfar Bahareh Hajikhani Forouzan Karimi Source Type: research
Bortezomib and Vorinostat Therapy as Maintenance Therapy Post Autologous Transplant for Non-Hodgkin's Lymphoma Using R-BEAM or BEAM Transplant Conditioning Regimen
CONCLUSIONS: BV can be given post-ASCT for NHL and produces excellent disease-free and overall survival rates.PMID:37708877 | DOI:10.1159/000533944
Source: Acta Haematologica - September 14, 2023 Category: Hematology Authors: Leona A Holmberg David G Maloney Laura Connelly-Smith Source Type: research
Non-hodgkin's lymphoma masquerading as a right atrial mass
Ann Card Anaesth. 2023 Apr-Jun;26(2):209-210. doi: 10.4103/aca.aca_119_22.NO ABSTRACTPMID:37706389 | DOI:10.4103/aca.aca_119_22
Source: Annals of Cardiac Anaesthesia - September 14, 2023 Category: Anesthesiology Authors: Prateek Arora Omer M Mujahid Subrata K Singha Source Type: research
Angioimmunoblastic T-cell Lymphoma Mimicking Systemic Lupus Erythematosus: A Case Report and Literature Review
CONCLUSION: Patients with AITL generally have a poor prognosis. Rarely do reported cases show AITL mimicking SLE. AITL should be considered during clinical practice to prevent missed diagnoses or misdiagnoses.PMID:37708543
Source: Alternative Therapies in Health and Medicine - September 14, 2023 Category: Complementary Medicine Authors: Yanni Wang Zhenglun Pan Source Type: research
Non-hodgkin's lymphoma masquerading as a right atrial mass
Ann Card Anaesth. 2023 Apr-Jun;26(2):209-210. doi: 10.4103/aca.aca_119_22.NO ABSTRACTPMID:37706389 | PMC:PMC10284470 | DOI:10.4103/aca.aca_119_22
Source: Annals of Cardiac Anaesthesia - September 14, 2023 Category: Anesthesiology Authors: Prateek Arora Omer M Mujahid Subrata K Singha Source Type: research
Anticancer Effects of Cell-Free Culture Supernatant of Escherichia coli in Bladder Cancer Cell Line: New Insight into the Regulation of Inflammation
In conclusion, our findings demonstrate that this compound is a potential candidate for the suppression of bladder cancer progression.PMID:37708921 | DOI:10.1016/j.gene.2023.147795
Source: Gene - September 14, 2023 Category: Genetics & Stem Cells Authors: Amirreza Mehmandar-Oskuie Masoud Tohidfar Bahareh Hajikhani Forouzan Karimi Source Type: research
Splenectomised Hodgkin lymphoma patients: does severe pneumococcal disease pose a problem today and what is the best long-term strategy?
Acta Oncol. 2023 Sep 14:1-3. doi: 10.1080/0284186X.2023.2256468. Online ahead of print.NO ABSTRACTPMID:37708099 | DOI:10.1080/0284186X.2023.2256468
Source: Acta Oncologica - September 14, 2023 Category: Cancer & Oncology Authors: Caroline E Weibull Jan Sj öberg Paul W Dickman Magnus Bj örkholm Source Type: research
